Hong Wang

Hong Wang is an accomplished computational chemist with substantial experience in drug discovery and development. Currently serving as Director of Computational Chemistry at Xenon Pharmaceuticals Inc. since February 2022, Hong has specialized in computational chemistry, cheminformatics, machine learning-based ADME modeling, and data analysis, while also advancing the computational infrastructure and developing tools to aid medicinal chemistry efforts. Prior roles include leadership positions at Paraza Pharma Inc., where Hong expanded computer-aided drug discovery (CADD) capabilities and managed various drug discovery projects using diverse methodologies. Hong’s academic background includes a PhD in Computational Biology from New York University, along with a Master’s in Molecular Biology and a Medical Doctorate in Clinical Medicine from Capital University of Medical Sciences in Beijing.